A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder

@article{Rickels2004ADP,
  title={A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder},
  author={K. Rickels and R. Mangano and A. Khan},
  journal={Journal of Clinical Psychopharmacology},
  year={2004},
  volume={24},
  pages={488-496}
}
  • K. Rickels, R. Mangano, A. Khan
  • Published 2004
  • Psychology, Medicine
  • Journal of Clinical Psychopharmacology
  • Abstract: Venlafaxine extended release (ER) is a dual serotonin-norepinephrine reuptake inhibitor previously shown to be effective in the treatment of major depressive disorder and generalized anxiety disorder. This placebo-controlled, multicenter, randomized, double-blind trial examined the efficacy and safety of venlafaxine ER in outpatients with generalized social anxiety disorder. Two hundred seventy-two outpatients were randomly assigned to receive either a flexible dose of venlafaxine ER… CONTINUE READING
    87 Citations

    Paper Mentions

    Interventional Clinical Trial
    Previous studies have demonstrated that venlafaxine significantly improves the language function of healthy subjects and increase of fMRI activation in cortical language area. This… Expand
    ConditionsIschemic Stroke, Subcortical Aphasia
    InterventionDrug
    Long-term efficacy of pregabalin in generalized anxiety disorder
    • 108
    Mirtazapine Treatment of Social Phobia in Women: A Randomized, Double-Blind, Placebo-Controlled Study
    • 61

    References

    SHOWING 1-10 OF 51 REFERENCES
    Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
    • 200